Yahoo Web Search

Search results

    • Multiple Sclerosis Highlights From AAN 2024

      Multiple Sclerosis Highlights From AAN 2024

      Medscape· 4 days ago

      Highlights in relapsing-remitting multiple sclerosis from AAN 2024 include pregnancy-related considerations, anti-CD20 drug-associated infection, and...

    • Q1 2024 Royalty Pharma PLC Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 13 hours ago

      But in summary, we have agreed to acquire royalties and milestones on Sanofi's frexalimab for approximately $525 million, including estimated transaction costs. This is an exciting development ...